Cancer Vaccines

Read full text Summarise with VIRAT
Authors: Ashwini Taware*, Chetana Mayekar, Manisha Nangude, Harsh Tapal, Pranali Vekhande, Manas Suryarao
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Cancer vaccines represent a promising approach in cancer immunotherapy aimed at stimulating the immune system to recognize and eliminate tumor cells. Despite early challenges and limited clinical success, recent advances in tumor genomics, antigen discovery, and vaccine technologies have significantly improved their potential. Personalized vaccines, neoantigen targeting, and mRNA-based platforms offer improved specificity and adaptability to tumor heterogeneity. The use of cancer vaccines in combination with other therapies and in early-stage or adjuvant settings further enhances their effectiveness. Although challenges remain, ongoing research suggests that cancer vaccines may play a vital role in future precision cancer treatment strategies.

Fields of Study & Subjects

Immunotherapy and Immune Responses Cancer Immunotherapy and Biomarkers Bacterial Cancer Therapy

Publication details

Journal / source
Zenodo (CERN European Organization for Nuclear Research)
Publication date
27 March 2026
Language
EN